|Oxford textbook of palliative medicine|
G Hanks, NI Cherny, NA Christakis, S Kaasa
Oxford university press, 2011
|Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 …|
C Allemani, T Matsuda, V Di Carlo, R Harewood, M Matz, M Nikšić, ...
The Lancet 391 (10125), 1023-1075, 2018
|Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea|
AP Abernethy, DC Currow, P Frith, BS Fazekas, A McHugh, C Bui
Bmj 327 (7414), 523-528, 2003
|A systematic review of prognostic/end-of-life communication with adults in the advanced stages of a life-limiting illness: patient/caregiver preferences for the content, style …|
SM Parker, JM Clayton, K Hancock, S Walder, PN Butow, S Carrick, ...
Journal of pain and symptom management 34 (1), 81-93, 2007
|Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomised controlled trial|
AP Abernethy, CF McDonald, PA Frith, K Clark, JE Herndon II, J Marcello, ...
The Lancet 376 (9743), 784-793, 2010
|Truth-telling in discussing prognosis in advanced life-limiting illnesses: a systematic review|
K Hancock, JM Clayton, SM Parker, S Wal der, PN Butow, S Carrick, ...
Palliative medicine 21 (6), 507-517, 2007
|Palliative cancer care a decade later: accomplishments, the need, next steps—from the American Society of Clinical Oncology|
FD Ferris, E Bruera, N Cherny, C Cummings, D Currow, D Dudgeon, ...
Journal of Clinical Oncology 27 (18), 3052-3058, 2009
|Clinical practice guidelines for communicating prognosis and end-of-life issues with adults in the advanced stages of a life-limiting illness, and their caregivers|
JM Clayton, KM Hancock, PN Butow, MHN Tattersall, DC Currow
The Medical Journal of Australia 186 (12), S77, 2007
|Lung cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK: a population-based study, 2004–2007|
S Walters, C Maringe, MP Coleman, MD Peake, J Butler, N Young, ...
Thorax 68 (6), 551-564, 2013
|Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: a randomized clinical trial|
JS Kutner, PJ Blatchford, DH Taylor, CS Ritchie, JH Bull, DL Fairclough, ...
JAMA internal medicine 175 (5), 691-700, 2015
|Sustaining hope when communicating with terminally ill patients and their families: a systematic review|
JM Clayton, K Hancock, S Parker, PN Butow, S Walder, S Carrick, ...
Psycho‐Oncology: Journal of the Psychological, Social and Behavioral …, 2008
|Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials|
JS Temel, AP Abernethy, DC Currow, J Friend, EM Duus, Y Yan, ...
The Lancet Oncology 17 (4), 519-531, 2016
|The Australia-modified Karnofsky Performance Status (AKPS) scale: a revised scale for contemporary palliative care clinical practice [ISRCTN81117481]|
AP Abernethy, T Shelby-James, BS Fazekas, D Woods, DC Currow
BMC palliative care 4 (1), 1-12, 2005
|Randomized controlled trial of a prompt list to help advanced cancer patients and their caregivers to ask questions about prognosis and end-of-life care|
JM Clayton, PN Butow, MHN Tattersall, RJ Devine, JM Simpson, ...
Journal of Clinical Oncology 25 (6), 715-723, 2007
|Physical, psychosocial, relationship, and economic burden of caring for people with cancer: a review|
A Girgis, S Lambert, C Johnson, A Waller, D Currow
Journal of oncology practice 9 (4), 197-202, 2013
|Once-daily opioids for chronic dyspnea: a dose increment and pharmacovigilance study|
DC Currow, C McDonald, S Oaten, B Kenny, P Allcroft, P Frith, M Briffa, ...
Journal of pain and symptom management 42 (3), 388-399, 2011
|Safety of benzodiazepines and opioids in very severe respiratory disease: national prospective study|
MP Ekström, A Bornefalk-Hermansson, AP Abernethy, DC Currow
Bmj 348, 2014
|Caregiving for the terminally ill: at what cost?|
SM Aoun, LJ Kristjanson, DC Currow, PL Hudson
Palliative medicine 19 (7), 551-555, 2005
|Preference for place of care and place of death in palliative care: are these different questions?|
M Agar, DC Currow, TM Shelby-James, J Plummer, C Sanderson, ...
Palliative medicine 22 (7), 787-795, 2008
|Efficacy of oral risperidone, haloperidol, or placebo for symptoms of delirium among patients in palliative care: a randomized clinical trial|
MR Agar, PG Lawlor, S Quinn, B Draper, GA Caplan, D Rowett, ...
JAMA internal medicine 177 (1), 34-42, 2017